208 related articles for article (PubMed ID: 20067787)
41. R-(-)-beta-O-methylsynephrine, a natural product, inhibits VEGF-induced angiogenesis in vitro and in vivo.
Kim NH; Pham NB; Quinn RJ; Kwon HJ
Biochem Biophys Res Commun; 2010 Aug; 399(1):20-3. PubMed ID: 20643105
[TBL] [Abstract][Full Text] [Related]
42. Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway.
Li M; Wu S; Liu Z; Zhang W; Xu J; Wang Y; Liu J; Zhang D; Tian H; Li Y; Ye W
Biochem Pharmacol; 2012 May; 83(9):1251-60. PubMed ID: 22305746
[TBL] [Abstract][Full Text] [Related]
43. LYP, a bestatin dimethylaminoethyl ester, inhibited cancer angiogenesis both in vitro and in vivo.
Gao JJ; Xue X; Gao ZH; Cui SX; Cheng YN; Xu WF; Tang W; Qu XJ
Microvasc Res; 2011 Sep; 82(2):122-30. PubMed ID: 21664364
[TBL] [Abstract][Full Text] [Related]
44. The effects of cadmium on VEGF-mediated angiogenesis in HUVECs.
Kim J; Lim W; Ko Y; Kwon H; Kim S; Kim O; Park G; Choi H; Kim O
J Appl Toxicol; 2012 May; 32(5):342-9. PubMed ID: 21425301
[TBL] [Abstract][Full Text] [Related]
45. Direct effects of fascaplysin on human umbilical vein endothelial cells attributing the anti-angiogenesis activity.
Zheng YL; Lu XL; Lin J; Chen HM; Yan XJ; Wang F; Xu WF
Biomed Pharmacother; 2010 Oct; 64(8):527-33. PubMed ID: 19932581
[TBL] [Abstract][Full Text] [Related]
46. Induced thyme product prevents VEGF-induced migration in human umbilical vein endothelial cells.
Krill D; Madden J; Huncik K; Moeller PD
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):275-81. PubMed ID: 21073864
[TBL] [Abstract][Full Text] [Related]
47. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.
Fernandez-Sauze S; Delfino C; Mabrouk K; Dussert C; Chinot O; Martin PM; Grisoli F; Ouafik L; Boudouresque F
Int J Cancer; 2004 Mar; 108(6):797-804. PubMed ID: 14712479
[TBL] [Abstract][Full Text] [Related]
48. Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivo.
Basile A; Del Gatto A; Diana D; Di Stasi R; Falco A; Festa M; Rosati A; Barbieri A; Franco R; Arra C; Pedone C; Fattorusso R; Turco MC; D'Andrea LD
J Med Chem; 2011 Mar; 54(5):1391-400. PubMed ID: 21280635
[TBL] [Abstract][Full Text] [Related]
49. Ethyl pyruvate, an anti-inflammatory agent, inhibits tumor angiogenesis through inhibition of the NF-κB signaling pathway.
Park SY; Yi EY; Jung M; Lee YM; Kim YJ
Cancer Lett; 2011 Apr; 303(2):150-4. PubMed ID: 21333439
[TBL] [Abstract][Full Text] [Related]
50. Antiangiogenic activity of ursolic acid.
Kanjoormana M; Kuttan G
Integr Cancer Ther; 2010 Jun; 9(2):224-35. PubMed ID: 20462855
[TBL] [Abstract][Full Text] [Related]
51. Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone.
Varinska L; van Wijhe M; Belleri M; Mitola S; Perjesi P; Presta M; Koolwijk P; Ivanova L; Mojzis J
Eur J Pharmacol; 2012 Sep; 691(1-3):125-33. PubMed ID: 22721615
[TBL] [Abstract][Full Text] [Related]
52. The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formation.
Li H; Shi X; Liu J; Hu C; Zhang X; Liu H; Jin J; Opolon P; Vannier JP; Perricaudet M; Janin A; Soria C; Lu H
Cancer Gene Ther; 2010 Oct; 17(10):700-7. PubMed ID: 20559333
[TBL] [Abstract][Full Text] [Related]
53. Indirubin-3'-monoxime, a derivative of a chinese antileukemia medicine, inhibits angiogenesis.
Kim JK; Shin EK; Kang YH; Park JH
J Cell Biochem; 2011 May; 112(5):1384-91. PubMed ID: 21337385
[TBL] [Abstract][Full Text] [Related]
54. Total glucosides of Paeonia lactiflora Pall inhibit vascular endothelial growth factor-induced angiogenesis.
Deng H; Yan C; Xiao T; Yuan D; Xu J
J Ethnopharmacol; 2010 Feb; 127(3):781-5. PubMed ID: 19914370
[TBL] [Abstract][Full Text] [Related]
55. Prevention of FGF-2-induced angiogenesis by scopoletin, a coumarin compound isolated from Erycibe obtusifolia Benth, and its mechanism of action.
Pan R; Gao X; Lu D; Xu X; Xia Y; Dai Y
Int Immunopharmacol; 2011 Dec; 11(12):2007-16. PubMed ID: 21896339
[TBL] [Abstract][Full Text] [Related]
56. Lonidamine causes inhibition of angiogenesis-related endothelial cell functions.
Del Bufalo D; Trisciuoglio D; Scarsella M; D'Amati G; Candiloro A; Iervolino A; Leonetti C; Zupi G
Neoplasia; 2004; 6(5):513-22. PubMed ID: 15548359
[TBL] [Abstract][Full Text] [Related]
57. Propolis suppresses tumor angiogenesis by inducing apoptosis in tube-forming endothelial cells.
Ohta T; Kunimasa K; Kobayashi T; Sakamoto M; Kaji K
Biosci Biotechnol Biochem; 2008 Sep; 72(9):2436-40. PubMed ID: 18776674
[TBL] [Abstract][Full Text] [Related]
58. Alchornea glandulosa ethyl acetate fraction exhibits antiangiogenic activity: preliminary findings from in vitro assays using human umbilical vein endothelial cells.
Lopes FC; Rocha A; Pirraco A; Regasini LO; Siqueira JR; Silva DH; Bolzani VS; Carlos IZ; Soares R
J Med Food; 2011 Oct; 14(10):1244-53. PubMed ID: 21663472
[TBL] [Abstract][Full Text] [Related]
59. Grifola frondosa (maitake mushroom) water extract inhibits vascular endothelial growth factor-induced angiogenesis through inhibition of reactive oxygen species and extracellular signal-regulated kinase phosphorylation.
Lee JS; Park BC; Ko YJ; Choi MK; Choi HG; Yong CS; Lee JS; Kim JA
J Med Food; 2008 Dec; 11(4):643-51. PubMed ID: 19053855
[TBL] [Abstract][Full Text] [Related]
60. Investigation of the marine compound spongistatin 1 links the inhibition of PKCalpha translocation to nonmitotic effects of tubulin antagonism in angiogenesis.
Rothmeier AS; Ischenko I; Joore J; Garczarczyk D; Fürst R; Bruns CJ; Vollmar AM; Zahler S
FASEB J; 2009 Apr; 23(4):1127-37. PubMed ID: 19056838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
